China Healthcare Biomarkers Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Healthcare Biomarkers industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GE Healthcare

    • Johnson and Johnson

    • Epigenomics AG

    • Roche Diagnostics

    • Abbott Laboratories

    • Siemens Healthcare GmbH

    • Merck

    • Qiagen NV

    • Bio-Rad Laboratories

    By Type:

    • Safety Biomarker

    • Validation Biomarker

    • Efficacy Biomarker

    By Application:

    • Disease Risk Assessment

    • Personalized Medicine

    • Drug Discovery & Development

    • Diagnostics Development

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Healthcare Biomarkers Market Overview 2018-2029

    • 1.1 China Healthcare Biomarkers Industry Development Overview

    • 1.2 China Healthcare Biomarkers Industry Development History

    • 1.3 China Healthcare Biomarkers Industry Market Size (2018-2029)

    • 1.4 China Healthcare Biomarkers Market Analysis by Type from Production Side

      • 1.4.1 China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Safety Biomarker (2018-2029)

      • 1.4.2 China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Validation Biomarker (2018-2029)

      • 1.4.3 China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Efficacy Biomarker (2018-2029)

    • 1.5 China Healthcare Biomarkers Market Analysis by Application from Consumption End

      • 1.5.1 China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Disease Risk Assessment (2018-2029)

      • 1.5.2 China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Personalized Medicine (2018-2029)

      • 1.5.3 China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Drug Discovery & Development (2018-2029)

      • 1.5.4 China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Diagnostics Development (2018-2029)

      • 1.5.5 China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Healthcare Biomarkers Market Analysis by Region

      • 1.6.1 North China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    Chapter 2 China Healthcare Biomarkers Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Healthcare Biomarkers Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Healthcare Biomarkers Market Status and Competition Analysis in 2023

      • 2.2.3 China Healthcare Biomarkers Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Healthcare Biomarkers Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Healthcare Biomarkers Industry Development

    Chapter 3 Healthcare BiomarkersIndustry Chain Analysis

    • 3.1 Healthcare Biomarkers Industry Chain

    • 3.2 Healthcare Biomarkers Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Healthcare Biomarkers Market

    • 3.3 Healthcare Biomarkers Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Healthcare Biomarkers Market

    Chapter 4 China Healthcare Biomarkers Market, by Type

    • 4.1 China Healthcare Biomarkers Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Healthcare Biomarkers Total Production Volume and Growth Rate from Production Side

    • 4.5 China Healthcare Biomarkers Production Volume and Growth Rate, by Type

      • 4.5.1 China Healthcare Biomarkers Production Volume and Growth Rate of Safety Biomarker

      • 4.5.2 China Healthcare Biomarkers Production Volume and Growth Rate of Validation Biomarker

      • 4.5.3 China Healthcare Biomarkers Production Volume and Growth Rate of Efficacy Biomarker

    Chapter 5 China Healthcare Biomarkers Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Healthcare Biomarkers Total Market Size and Growth Rate from Consumption End

    • 5.5 China Healthcare Biomarkers Market Size and Growth Rate, by Application

      • 5.5.1 China Healthcare Biomarkers Market Size and Growth Rate of Disease Risk Assessment

      • 5.5.2 China Healthcare Biomarkers Market Size and Growth Rate of Personalized Medicine

      • 5.5.3 China Healthcare Biomarkers Market Size and Growth Rate of Drug Discovery & Development

      • 5.5.4 China Healthcare Biomarkers Market Size and Growth Rate of Diagnostics Development

      • 5.5.5 China Healthcare Biomarkers Market Size and Growth Rate of Others

    Chapter 6 China Healthcare Biomarkers Market, by Region

    • 6.1 China Healthcare Biomarkers Production Volume and Production Value, by Region

    • 6.2 China Healthcare Biomarkers Sales Volume and Sales Value, by Region

    Chapter 7 North China Healthcare Biomarkers Market Analysis

    • 7.1 North China Healthcare Biomarkers Market, by Type

    • 7.2 North China Healthcare Biomarkers Market, by Application

    Chapter 8 Central China Healthcare Biomarkers Market Analysis

    • 8.1 Central China Healthcare Biomarkers Market, by Type

    • 8.2 Central China Healthcare Biomarkers Market, by Application

    Chapter 9 South China Healthcare Biomarkers Market Analysis

    • 9.1 South China Healthcare Biomarkers Market, by Type

    • 9.2 South China Healthcare Biomarkers Market, by Application

    Chapter 10 East China Healthcare Biomarkers Market Analysis

    • 10.1 East China Healthcare Biomarkers Market, by Type

    • 10.2 East China Healthcare Biomarkers Market, by Application

    Chapter 11 Northeast China Healthcare Biomarkers Market Analysis

    • 11.1 Northeast China Healthcare Biomarkers Market, by Type

    • 11.2 Northeast China Healthcare Biomarkers Market, by Application

    Chapter 12 Southwest China Healthcare Biomarkers Market Analysis

    • 12.1 Southwest China Healthcare Biomarkers Market, by Type

    • 12.2 Southwest China Healthcare Biomarkers Market, by Application

    Chapter 13 Northwest China Healthcare Biomarkers Market Analysis

    • 13.1 Northwest China Healthcare Biomarkers Market, by Type

    • 13.2 Northwest China Healthcare Biomarkers Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GE Healthcare

        • 14.1.1 GE Healthcare Company Profile

        • 14.1.2 GE Healthcare Healthcare Biomarkers Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Johnson and Johnson

        • 14.2.1 Johnson and Johnson Company Profile

        • 14.2.2 Johnson and Johnson Healthcare Biomarkers Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Epigenomics AG

        • 14.3.1 Epigenomics AG Company Profile

        • 14.3.2 Epigenomics AG Healthcare Biomarkers Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Roche Diagnostics

        • 14.4.1 Roche Diagnostics Company Profile

        • 14.4.2 Roche Diagnostics Healthcare Biomarkers Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Abbott Laboratories

        • 14.5.1 Abbott Laboratories Company Profile

        • 14.5.2 Abbott Laboratories Healthcare Biomarkers Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Siemens Healthcare GmbH

        • 14.6.1 Siemens Healthcare GmbH Company Profile

        • 14.6.2 Siemens Healthcare GmbH Healthcare Biomarkers Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck

        • 14.7.1 Merck Company Profile

        • 14.7.2 Merck Healthcare Biomarkers Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Qiagen NV

        • 14.8.1 Qiagen NV Company Profile

        • 14.8.2 Qiagen NV Healthcare Biomarkers Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bio-Rad Laboratories

        • 14.9.1 Bio-Rad Laboratories Company Profile

        • 14.9.2 Bio-Rad Laboratories Healthcare Biomarkers Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Healthcare Biomarkers Industry Research Conclusions

    • 15.2 Healthcare Biomarkers Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Healthcare Biomarkers Industry Market Size (2018-2029)

    • Figure China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Safety Biomarker (2018-2029)

    • Figure China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Validation Biomarker (2018-2029)

    • Figure China Healthcare Biomarkers Production Volume, Production Value and Growth Rate of Efficacy Biomarker (2018-2029)

    • Figure China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Disease Risk Assessment (2018-2029)

    • Figure China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Personalized Medicine (2018-2029)

    • Figure China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Drug Discovery & Development (2018-2029)

    • Figure China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Diagnostics Development (2018-2029)

    • Figure China Healthcare Biomarkers Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Central China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure South China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure East China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Healthcare Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Healthcare Biomarkers Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Healthcare Biomarkers Market Share by Type in 2018

    • Figure China Healthcare Biomarkers Market Share by Type in 2023

    • Figure China Healthcare Biomarkers Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Healthcare Biomarkers Production Volume and Growth Rate of Safety Biomarker (2018-2023)

    • Figure China Healthcare Biomarkers Production Volume and Growth Rate of Validation Biomarker (2018-2023)

    • Figure China Healthcare Biomarkers Production Volume and Growth Rate of Efficacy Biomarker (2018-2023)

    • Figure China Healthcare Biomarkers Market Share by Application in 2018

    • Figure China Healthcare Biomarkers Market Share by Application in 2023

    • Figure China Healthcare Biomarkers Total Market Size and Growth Rate from Consumption End

    • Figure China Healthcare Biomarkers Market Size and Growth Rate of Disease Risk Assessment (2018-2023)

    • Figure China Healthcare Biomarkers Market Size and Growth Rate of Personalized Medicine (2018-2023)

    • Figure China Healthcare Biomarkers Market Size and Growth Rate of Drug Discovery & Development (2018-2023)

    • Figure China Healthcare Biomarkers Market Size and Growth Rate of Diagnostics Development (2018-2023)

    • Figure China Healthcare Biomarkers Market Size and Growth Rate of Others (2018-2023)

    • Table China Healthcare Biomarkers Production Volume by Region (2018-2023)

    • Table China Healthcare Biomarkers Production Volume Share by Region (2018-2023)

    • Figure China Healthcare Biomarkers Production Volume Share by Region (2018-2023)

    • Table China Healthcare Biomarkers Production Value by Region (2018-2023)

    • Table China Healthcare Biomarkers Production Value Share by Region (2018-2023)

    • Figure China Healthcare Biomarkers Production Value Share by Region (2018-2023)

    • Table China Healthcare Biomarkers Sales Volume by Region (2018-2023)

    • Table China Healthcare Biomarkers Sales Volume Share by Region (2018-2023)

    • Figure China Healthcare Biomarkers Sales Volume Share by Region (2018-2023)

    • Table China Healthcare Biomarkers Sales Value by Region (2018-2023)

    • Table China Healthcare Biomarkers Sales Value Share by Region (2018-2023)

    • Figure China Healthcare Biomarkers Sales Value Share by Region (2018-2023)

    • Table North China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table North China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure North China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table North China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table North China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure North China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Central China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table Central China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Central China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table Central China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table Central China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Central China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table South China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table South China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure South China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table South China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table South China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure South China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table East China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table East China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure East China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table East China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table East China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure East China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Northeast China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table Northeast China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Northeast China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table Northeast China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table Northeast China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Southwest China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table Southwest China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Southwest China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table Southwest China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table Southwest China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Northwest China Healthcare Biomarkers Production Volume by Type (2018-2023)

    • Table Northwest China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Northwest China Healthcare Biomarkers Production Volume Share by Type (2018-2023)

    • Table Northwest China Healthcare Biomarkers Sales Volume by Application (2018-2023)

    • Table Northwest China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Healthcare Biomarkers Sales Volume Share by Application (2018-2023)

    • Table GE Healthcare Company Profile

    • Table GE Healthcare Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Johnson and Johnson Company Profile

    • Table Johnson and Johnson Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Epigenomics AG Company Profile

    • Table Epigenomics AG Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Siemens Healthcare GmbH Company Profile

    • Table Siemens Healthcare GmbH Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Qiagen NV Company Profile

    • Table Qiagen NV Healthcare Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories Company Profile

    • Table Bio-Rad Laboratories Healthcare Biomarkers Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.